Becton Dickinson Executive Summary Problem
|
|
- Nathan Horton
- 5 years ago
- Views:
Transcription
1 Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos Professor Alia Crocker Strategic Problem Solving December 8 th 2015 Becton Dickinson Executive Summary Problem Becton Dickinson (BD) has been one of the leaders in medical technology since its founding in BD currently has 80% market share in the global syringe market. As the leader in this market, BD has come under a lot of scrutiny around anti-trust laws and FDA regulations. In 2002 and 2007, BD settled in the amount of $100 million and $340 million under anti-trust laws and not holding up to FDA rules and regulations. With 80% market share and a global footprint, BD decided to focus on safety and reliability in regards to their product portfolio. Therefore, BD merged with CareFusion, a medical management company with a focus on software-driven products, for $12.2 billion. There were many reasons that Becton Dickinson decided to merge with CareFusion as a value-added approach. However, this merger also produced many unforeseen challenges as well. BD wanted to spark a culture shift within the company since CareFusion was a young, agile, and entrepreneurial company. But, CareFusion operated this way at the cost of FDA rules and regulations. With being involved in kickback lawsuits pre-merger and multiple Class I recalls post-merger, CareFusion was not investing enough money or effort into FDA rules and regulations. What can Becton Dickinson do to overcome the challenges created by the merger with CareFusion in regards to the safety and reliability of its products? Proposed Solutions 1. Fully integrate CareFusion into Becton Dickinson s operations Since BD wants to focus on the reliability and safety of their products, this solution would allow BD to have more control over CareFusion s processes. This solution will further streamline the medical management processes between the two companies. By implementing this solution, this will further strengthen the relationship with the Cambridge Trust Company, who focuses on sustainable and responsible investment practices. 2. Create a promotional campaign around safety and reliability while investing in an FDA regulations training program for new and current employees This is the key factor when moving forward for BD. Through traditional advertising platforms such as business and healthcare magazines and press releases, BD can prove to its customers that they are focusing on continual improvement in regards to the safety and reliability of their products. We believe that BD should implement the above solutions to address the safety and reliability problems created by the merger with CareFusion. However, these solutions will require further monetary investments moving forward.
2 Becton Dickinson Becton Dickinson and Co. (BD) has existed in various forms since 1897, having been founded by American businessmen Maxwell W. Becton and Fairleigh S. Dickinson. Its initial business model was based around the production and sale of needles and syringes for medical use. Today, the company s largest segment, BD Medical, still serves this purpose producing 80% of all syringes globally. Additionally, BD Medical produces and sells surgical equipment, catheters, and critical care systems. The company also has two additional segments: BD Diagnostics, which is responsible for the design, production, and sale of blood collection systems, blood culturing systems, disease testing systems, and cancer screening equipment (among other products); and BD Biosciences, which designs, produces, and sells laboratory equipment for the sorting and analysis of cells and antibodies. Furthermore, BD has over 30 wholly owned subsidiaries in the medical care industry, located both in the United States and internationally. Financially, BD is among the world s largest in the Medical Technology Industry, reporting revenues upwards of $8.4 Billion in its most recent fiscal year. Aside from its strict business activities, BD has several charitable and environmental objectives which it takes very seriously. Charitable organizations to which BD has donated funds, product, and expertise include: UNICEF, American Red Cross, the U.S. President s Emergency Plan for AIDS Relief, Stop TB Partnership, the Global Business Coalition on Health, and programs at Columbia University, the University of Virginia, and Fairleigh Dickinson University (named after BD co-founder Fairleigh Dickinson). BD also has an involved Sustainability strategy and Sustainability goals for 2020, based on the ideas of Innovation (developing unique solutions for disease management and worker/patient safety), Access (creating low-cost solutions to provide health care in resource-limited populations), Efficiency (reducing greenhouse gas emissions and life-cycle impacts of products), and Empowerment (increasing diversity of workforce, achieving superior safety performance, and driving social impact through volunteer programs). CareFusion Merger In March 2015, Becton Dickinson Co. made the strategic and complimentary decision to acquire CareFusion Corp. for $12.2 billion. Becton Dickinson is the leader in syringe manufacturing and CareFusion has strong capabilities in technological medicine dispensing. Becton Dickinson is confident that this will allow them to become the global leader in medication management and patient safety solution. This portfolio approach encourages innovation, globalization, and value-adding impact through the complimentary solutions that the merge provides. The merge has significantly reduced costs without compensating the quality and value delivered to their customers. The products that the two companies provide perfectly align each other, which essentially simplifies the entire process. By 2018, $250 million will be saved through reducing overhead expenses, combining operations, and lowering manufacturing operations (Bloomberg). These savings will then be reflected through lowering the costs passed onto the hospitals. In both the U.S. and around the world, hospitals are under extreme pressure to
3 reduce costs and increase their efficiency. Hospitals are now turning towards buying in large bulks as a method to lower their costs and maximize volume. The Becton Dickinson and CareFusion merge focuses hospitals needs for improved efficiency and cost reduction by creating a one-stop-shop (Bloomberg). Becton Dickinson will now be able to offer a wider range of services like: drug preparation, dispensing on the hospital floor, patient administration and monitoring. The expanded services and capabilities of the merge will put Becton Dickinson ahead in the $20 billion medication management market. CareFusion will be able to expand their services globally through leveraging Becton Dickinson s global presence. 60% of Becton Dickinson s sales are abroad, while only a mere 25% of CareFusion s are abroad. The merge caters to emerging markets and already developed markets by offering a proactive approach in the medical industry. With their different geographical and service strengths, they are able to utilize and compliment their research and development to expand at a much more rapid rate. Globally expanding the services of CareFusion will emphasize Becton Dickinson s ongoing focus and vision of being customercentric. With global healthcare needing to focus more on doing more with less, the Becton Dickinson and CareFusion merge addresses the struggles in all kinds of markets. Becton Dickinson and Retractable Technologies Lawsuits Becton Dickinson also has an unfortunate history concerning lawsuits. In 1997, Retractable Technologies came out with a new syringe that was much safer for hospital personnel since it eliminated needle-sticks entirely. Eliminating needle-sticks prevented the transfer of infectious diseases from the patient to the hospital personnel through accidental syringe pokes during treatment. Since BD controls 80% of the syringe market in America, it is safe to say that their syringes contributed to a large amount of the 385,000 needle sticks that occur each year, according to the CDC. Retractable Technologies worked with BD to have them license this new and better syringe, the VaishPoint. Talks died when BD did not want to commit the finances in order to retool their technology to produce the VanishPoint syringe. After talks subsided, RT found themselves being locked out of the market. Hospital supply purchasing went through group purchasing organizations, or GPOs, which helped them buy bulk at discount. Vendors, like BD, pay the GPO administrative costs so that the GPOs only offer a narrow group of vendors available to the Hospitals, keeping out less prominent companies like RT. Hospitals simply did not want to break the contracts that they had with companies like BD, even though RT claimed to have superior technology. In 2002, RT sued BD under the Sherman Antitrust Act, claiming that BD monopolized the industry, BD settled for $100 million. In 2007, RT sued BD again. This time, RT attacked the inferior syringes that BD produced saying they did not comply with federal safety laws. The suit claimed that BD s safest needle only created more opportunities for needle-sticks. Also, that BD kept their subpar syringe on the market to drive down the perceived need for the VanishPoint while lying about the sharpness and accuracy of their own needles. After six years in court, BD was found guilty of monopolizing and lying to their customers. They were ordered to pay $340 million in
4 damages to RT and admit that they had lied. After these two suits, BD still decided to not license the VanishPoint from RT, but rather merge with CareFusion. This was not the first time that BD was found to have price-fixing violations. In 1960, BD was cited by the Justice Department for price-fixing. To avoid maximum repercussions, BD switched from glass to plastic syringes to remain on top of the syringe industry. The merger with CareFusion is a promising step in BDs commitment to improving the safety of their syringes. CareFusion Lawsuits and Recalls With the merger of BD and CareFusion completed in March of 2015, there are also many negative impacts to consider. The medical technology industry is built around strict rules and regulations to stress the ethical impact of leading companies. Before the merger took place, CareFusion was involved in a lawsuit in January of 2014 regarding kickbacks brought up by a former vice president of regulatory affairs at CareFusion, Cynthia Kirk. Dr. Charles Denham confirmed that CareFusion paid his company, Health Care Concepts Corporation, $11.6 million to promote their product ChloraPrep. To strengthen the issue, at the time of the kickback, Dr. Denham was the co-chair of a National Quality Forum committee that provided industry guidance on a range of patient-safety topics. CareFusion agreed to a settlement of $40.1 million for the kickbacks as well as marketing the product for unapproved uses. The United States contends that CareFusion's payments to HCC were made for the purpose of influencing Dr. Denham's work as co-chair of the Safe Practices Committee and for the purpose of inducing Dr. Denham to recommend, promote and/or arrange for the purchase of CareFusion's product, ChloraPrep, in violation of the federal antikickback statute ( This lawsuit might act as a reason for CareFusion to merge with Becton Dickinson as a way to increase the ethical decisions of this young company. However, there have even been some negative implications post-merger as well. The merger between BD and CareFusion was supposed to act as a streamlining process in terms of both product design as well as rules and regulations. BD was searching for a young software-focused company to implement these technologies into their physical products whereas CareFusion needed assistance in quality control processes in regards to industry regulations. However, the FDA has issued two Class I recalls (most severe and dangerous) on CareFusion products since the merger took place. CareFusion s Avea Ventilator was recalled in May of 2015 as a result of a potential malfunction of the 5 psi pressure transducer. The most important recall regarding the merger is related to CareFusion s Alaris Syringe Pump. This product is essential in regards to the merger between BD and CareFusion as BD is the leading producer of syringes worldwide. One of the most significant criterion of the merger was CareFusion s software accuracy when it comes to fluid delivery. However, the Alaris Syringe Pump has an extreme failure in regards to a visible alarm to stop supplying infusion to the patient. The pump does not
5 react to any error code key presses until the product is detached and reattached to the PC unit. According to the FDA, failure of syringe module may result in a delay or interruption of therapy and can lead to serious patient injury or death. This recall that occurred in July of 2015 causes a major issue for Becton Dickinson. On top of CareFusion s leniency towards industry regulations, the company s quality control is not performing as anticipated. Recommendations for Becton Dickinson Recommendation 1: Becton Dickinson should fully assimilate CareFusion and its entire operations under the name of BD. This will expedite the process of improving upon the safety of the syringe while showing how much BD believes in the technology offered by CareFusion. Though both companies are under scrutiny by the press due to their problems in the past, they are showing a lot of progress on their merger. The Cambridge Trust Company is a wealth management company that only does Sustainable and Responsible Investing (SRI - an investment discipline that considers environmental, social, and corporate governance criteria to generate long-term competitive financial return and positive impact) has invested in Becton Dickinson due to their strategic acquisition of CareFusion. The Cambridge Trust Company does first hand research by directly contacting and investigating the companies they invest in. Their investment in BD shows how the merger between Becton Dickinson and CareFusion has a big positive social impact. Recommendation 2: Create an advertising campaign promoting how Becton Dickinson is a very responsible company and that it continuously improves upon the safety and reliability of its products. Even though, DB is not selling their products directly to the people who need them, it will help BD regain trust while showing the dedication for improved safety. This campaign should be targeted to the general public through both press releases and traditional advertising channels such as: TV commercials, Healthcare magazine and radio advertising. The press releases would be comprised of formal presentations of the specific facts related to the improvements BD has made to its products. These improvements would include further investments in FDA regulation training for new and current employees at both CareFusion and BD. The commercial advertising should have content that relates to the people who might benefit from the products that BD is making while portraying trust and safety to the consumers. By implementing the above recommendations, Becton Dickinson will address the safety and regulation concerns created through the merger with CareFusion. It is extremely important for Becton Dickinson to gain lost brand equity after multiple lawsuits and recalls that have taken place recently. With that being said, the above solutions will require further monetary investments in order to gain back the trust of its customers.
6 Works Cited "Background and Definitions." FDA. U.S. Food and Drug Administration. Web. 2 Dec "BD: Medical Supplies, Devices and Technology; Laboratory Products; Antibodies." BD: Medical Supplies, Devices and Technology; Laboratory Products; Antibodies. Web. 2 Dec "BD 2014 Annual Report." BD. Web. 2 Dec "Becton Dickinson Acquisition of CareFusion - Frequently Asked Questions for Shareholders." BD. Web. 2 Dec "CareFusion Alaris Syringe Pump Alarm Error May Cause Interruption of Therapy." FDA. U.S. Food and Drug Administration, 2 July Web. 2 Dec "Carefusion Provides Update on Voluntary Global Recall of Avea Ventilator." FDA. U.S. Food and Drug Administration, 27 May Web. 2 Dec Carlson, Joe. "NQF Panel Member Admits He Got $11M from CareFusion, but Calls Kickback Allegations Surprising." Modern Healthcare. Modern Healthcare, 21 Jan Web. 2 Dec Cortez, Michelle, and Matthew Monks. "Becton Dickinson Agrees to Acquire CareFusion for $12.2B." Bloomberg Business. Bloomberg, 5 Oct Web. 2 Dec Dayen, David. "Bring Back Antitrust." The American Prospect. Web. 2 Dec Rockoff, Jonathan, and Dana Mattioli. "Becton Dickinson to Buy CareFusion for $12.2 Billion." WSJ. The Wall Street Journal, 5 Oct Web. 2 Dec Stempel, Jonathan. "CareFusion to Pay $40 Million to Settle U.S. Kickbacks Lawsuit." Reuters. Thomson Reuters, 9 Jan Web. 2 Dec
By Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos
By Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos Becton Dickinson Company Overview BD has been a player in the MedTech industry since it was founded in 1897, originally
More informationQuestioning $1 Million Fee in a Needle Deal
July 19, 2002 Questioning $1 Million Fee in a Needle Deal By BARRY MEIER with MARY WILLIAMS WALSH group that buys medical supplies for a third of the nation's hospitals received two highly unusual payments
More informationBecton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationA review of the role and costs of clinical commissioning groups
A picture of the National Audit Office logo Report by the Comptroller and Auditor General NHS England A review of the role and costs of clinical commissioning groups HC 1783 SESSION 2017 2019 18 DECEMBER
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationAbbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO
Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO FORWARD LOOKING STATEMENT Some statements in this presentation may be forward-looking
More informationDealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.
Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:
More informationJean W. Frydman Partner
Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary
More informationUNLOCKING THE VALUE OF SASB STANDARDS
CASE STUDY UNLOCKING THE VALUE OF SASB STANDARDS SUSTAINABILITY IS CRITICAL TO OUR BUSINESS PERFORMANCE, HELPING US MITIGATE RISK, ENHANCE QUALITY, INCREASE EFFICIENCY, AND DRIVE INNOVATION. Medtronic
More informationFY2005 Results Briefing Session. May 24, 2006
FY2005 Results Briefing Session May 24, 2006 1 Statements made in this document with respect to SQUARE ENIX CO., LTD. and consolidated subsidiaries' (together, "SQUARE ENIX") plans, estimates, strategies
More informationMedtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year
www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for
More informationDriving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China
Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant
More informationGOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2
GOVERNING BODY MEETING in Public 25 April 2018 Paper Title Paper Author(s) Jerry Hawker Accountable Officer NHS Eastern Cheshire CCG The Future of CCG Commissioning in Cheshire Alison Lee Accountable Officer
More informationHospital Products Get Seal of Approval at a Price
April 23, 2002 Hospital Products Get Seal of Approval at a Price By BARRY MEIER group that says its mission is to find the best medical supplies for some of the nation's biggest children's hospitals is
More informationMenu. Analog and Embedded Processing. TI at a glance. Innovation. Manufacturing. University and student engagement. Our commitment and values.
Menu TI at a glance Analog and Embedded Processing Innovation Manufacturing Markets Financials University and student engagement Our commitment and values TI at a glance Global semiconductor design and
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationMenu. Analog and Embedded Processing. TI at a glance. Innovation. Manufacturing. University and student engagement. Our commitment and values.
Menu TI at a glance Analog and Embedded Processing Innovation Manufacturing Markets Financials University and student engagement Our commitment and values TI at a glance Global semiconductor design and
More informationBloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs
Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs Antitrust 1. Anti-Counterfeiting for Licensed Products: What You Don't Know Can Hurt Your Business 2. Antitrust Investigations:
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationVENTURE CAPITAL USAGE AND ITS STAGES
VENTURE CAPITAL USAGE AND ITS STAGES G.Gayathri II MBA, Anna University Regional Campus, Coimbatore Project trainee, Technip India Limited, Guindy ABSTRACT Venture capital is long term financial assistance
More informationImplantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,
Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User
More informationModel Based Design Of Medical Devices
Model Based Design Of Medical Devices A Tata Elxsi Perspective Tata Elxsi s Solutions - Medical Electronics Abstract Modeling and Simulation (M&S) is an important tool that may be employed in the end-to-end
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationThe FDA: Merging Innovation and Opportunity to Impact Public Health
The FDA: Merging Innovation and Opportunity to Impact Public Health Jonathan Sackner-Bernstein, MD, FACC Associate Center Director, Post Market Operations Center for Devices and Radiologic Health U.S.
More informationMessage from the CEO. 4 OMRON Corporation
Message from the CEO 4 OMRON Corporation Achieving growth through a stronger earnings structure. Solving social issues through new technologies and innovative concepts. Yoshihito Yamada President and CEO
More informationPatent. Fish &Richardson
Patent Fish &Richardson > > 0 >> A 5G2 > > 0 0 >> >> 1 8 0 9 G H 3 0 H O 9 P D 4 A 4 4 > 6 7 0 1 6 7 A B 9 3 spark INNOVATION, > * 7 / / / to a protected PORTFOLIO As one of the world s premier intellectual
More informationComputers and Medicine
Illinois Institute of Technology Computers and Medicine Alexander M. Nicoara CS485: History of Computers Professor Charles Bauer April 10th, 2016 What is the background of the topic? Computers play an
More informationDaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector
More informationV I S I O N South Wolf Road, Wheeling, IL
VISION 2018 PROTECT-A-BED 2000 to 2018 and beyond! In the year 2000 Protect-A-Bed established a brand new product concept in the United States: MATTRESS PROTECTION! PROTECT - A - BED VISION 2018 1 Where
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationTrader Media Group is a perfect example of an established media company thriving online
Apax Partners Annual Report 2009 2 How do we we release potential? Media 44 45 Better handling Trader Media Group Apax Partners identified the strong potential of the Auto Trader brand and products in
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationTrends in Healthcare Investments and Exits 2018
Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationFSIC FRANCHISE. Frequently asked questions
Frequently asked questions FSIC FRANCHISE 1. What are the details of the announced transaction? FS Investments ( FS ) and KKR Credit ( KKR ) announced an agreement to form a partnership to provide investment
More informationTHE STARS GROUP 2017 ANNUAL AND SPECIAL MEETING MANAGEMENT PRESENTATION MAY 10, 2018, TORONTO, 11:30 (ET)
Please Note: THE STARS GROUP 2017 ANNUAL AND SPECIAL MEETING MANAGEMENT PRESENTATION MAY 10, 2018, TORONTO, 11:30 (ET) Some of our comments today will contain forward-looking information and statements
More informationKKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018
KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018 KKR Today Private Markets Public Markets Capital Markets Principal Activities $104bn AUM $91bn AUM Global Franchise $19bn
More informationJ.P. Morgan Healthcare Conference Summary Transcript
J.P. Morgan Healthcare Conference Summary Transcript Good afternoon, everyone. I'm Shigeo Taniuchi. I'm President and COO of Santen Pharmaceutical. I joined Santen in 1996, and I became the President and
More informationSUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS
SUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS Glenn E. Pearson, FACHE Principal, Pearson Health Tech Insights, LLC Georgia HFMA/Georgia HIMSS August 2, 2017 Outline
More informationCRAWFORD & COMPANY Annual Meeting of Shareholders
CRAWFORD & COMPANY Annual Meeting of Shareholders May 11, 2016 Charles H. Ogburn, Non-executive Chairman of the Board Harsha V. Agadi, Interim President and Chief Executive Officer Agenda Welcome D. Richard
More informationHEALTH INNOVATION EXCHANGE
HEALTH INNOVATION EXCHANGE AGENDA Welcome: Mark Basnett, Liverpool LEP & Local Growth Hub - Keynote presentation: Charlotte Lewis & Robert McGough, Commercial Healthcare Hill Dickinson LLP - Presentation:
More informationInclusion: All members of our community are welcome, and we will make changes, when necessary, to make sure all feel welcome.
The 2016 Plan of Service comprises short-term and long-term goals that we believe will help the Library to deliver on the objectives set out in the Library s Vision, Mission and Values statement. Our Vision
More informationTRIUMF ACCELERATING CANADIAN BUSINESS THROUGH SCIENCE AND INNOVATION Pre-Budget Consultation
Canada s national laboratory for particle and nuclear physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules TRIUMF ACCELERATING CANADIAN BUSINESS THROUGH
More informationPOWERING THE GLOBAL ENERGY DEMAND
POWERING THE GLOBAL ENERGY DEMAND Headquartered in San Diego, California, USA, Solar Turbines Incorporated, a subsidiary of Caterpillar Inc., is one of the world s leading manufacturers of industrial gas
More informationPatent Assertion Entity Activity: An FTC Study
Patent Assertion Entity Activity: An FTC Study Suzanne Munck Chief Counsel for Intellectual Property Deputy Director, Office of Policy Planning U.S. Federal Trade Commission PLI 11th Annual Patent Law
More informationCEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC
CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: July 10, 2017 Human Factors Firm helping Medical Device and Pharmaceutical Companies Ensure Usability, Safety, Instructions and Training
More informationPatenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1
Patenting Strategies The First Steps Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1 Contents 1. The pro-patent era 2. Main drivers 3. The value of patents 4. Patent management 5. The strategic
More informationCompression Therapy - Medical Devices Pipeline Assessment, 2017
Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from
More informationUkrGasVydobuvannya Public invitation for Expression of Interest for participation in the project of gas production enhancement
UkrGasVydobuvannya Public invitation for Expression of Interest for participation in the project of gas production enhancement October 2018 Kyiv Summary and objectives One of the current UkrGasVydobuvannya
More informationSparking a New Economy. Canada s Advanced Manufacturing Supercluster
Sparking a New Economy Canada s Advanced Manufacturing Supercluster Canada s Advanced Manufacturing Supercluster Canada's Advanced Manufacturing Supercluster Strategy will leverage Canada s innovation
More informationUBS Global Healthcare Services Conference February 14, 2006
UBS Global Healthcare Services Conference February 14, 2006 Forward-Looking Statements This presentation contains forward-looking statements that are subject to risks and uncertainties including, but not
More informationConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationKKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform. December 2017
KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform December 2017 Strategic BDC Partnership Introduction On December 11, 2017, KKR and FS Investments
More informationResearch on Venture Capital Exit for Science and Technology Innovation Enterprise Ding Wenhui Guangdong University of Science and Technology
5th International Conference on Social Science, Education and Humanities Research (SSEHR 2016) Research on Venture Capital Exit for Science and Technology Innovation Enterprise Ding Wenhui Guangdong University
More informationThe partner of choice for self-care products
The partner of choice for self-care products Venture Life Group plc Full Year Results Presentation 2017 22 March 2018 2017 highlights Revenues up 12% to 16.1m (2016: 14.3m) Gross profit increased 18% to
More informationINTEL INNOVATION GENERATION
INTEL INNOVATION GENERATION Overview Intel was founded by inventors, and the company s continued existence depends on innovation. We recognize that the health of local economies including those where our
More informationErratum to the Press Release 2017 annual results - NRJ Group. dated March 15, 2018
Paris, March 20, 2018 5:45 pm Erratum to the Press Release 2017 annual results - NRJ Group dated March 15, 2018 An editorial error was made in the press release dated March 15, 2018 (English version only)
More informationAutomotive Supply Industry Law
Automotive Supply Industry Law A Better Partnership Warner Norcross & Judd LLP 1 The speed at which your business grows depends upon the ability to anticipate what s around the curve. Our automotive attorneys
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE INTELLECTUAL VENTURES II LLC, Plaintiffs, v. Civil Action No. JURY TRIAL DEMANDED CANON INC. and CANON U.S.A., INC., Defendants. COMPLAINT
More informationNOTICE To the Trustee of
NOTICE To the Trustee of Garfunkelux Holdco 3 S.A. (the Issuer ) 365,000,000 7.50% Senior Secured Notes due 2022 ISIN: XS1263891910, Common Code: 126389191 (Regulation S) ISIN: XS1263892561, Common Code:
More informationSOLUTIONS WITH INSIGHT
SOLUTIONS WITH INSIGHT FROM THE JOENSUU REGION Flexibility, reliability and high quality have made the Joensuu Region a pioneer of medical solutions. Years of experience and continuing development guarantee
More information261 Gorham Road South Portland, ME Company Profile
Company Profile Preservation Management, Inc. (PMI) has been providing comprehensive residential and commercial property management services since 1990. Over the last two decades PMI has grown to manage
More informationThomson Reuters Legal
Reuters/Suhaib Salim Peter Warwick President & CEO Deutsche Bank European TMT Conference September 9, 2010 Thomson Reuters Special Note Safe Harbor / Forward-Looking Statements The following discussion
More informationMining. Construction Family Offices. Life Sciences Life Sciences. Oil & Gas. Automotive. Mining. ealth Law. ommercial Finance. conomic Incentives
Litigation Human Resources Trusts & Estates Oil & Gas Oil & Gas Life Sciences Financial Services conomic Incentives Family Offices Life Sciences Business & Corporate Services Litigation Real Estate/Development
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationUCT Coatings, Inc. Fiscal Year 2014 Annual Financial Report And Shareholder Letter
UCT Coatings, Inc. UCT Employees IKS Sales Team Fiscal Year 2014 Annual Financial Report And Shareholder Letter Shareholder Report - 2014 2014 FINANACIAL RESULTS Fiscal 2014 was a difficult year for UCT
More informationGENDER PAY GAP REPORT
WRAFTON LABORATORIES GENDER PAY GAP REPORT APRIL 2017 Introduction Wrafton Laboratories Limited is part of Perrigo, a global pharmaceutical company that provides Quality Affordable Healthcare Products
More informationUSTGlobal. 3D Printing. Changing the Face of Healthcare
USTGlobal 3D Printing Changing the Face of Healthcare UST Global Inc, November 2017 Table of Contents Introduction 3 Challenges 3 Impact of 3D Printing 4 IT Solutions for 3D Printing 5 How UST Global Can
More informationReport for the Global South ehealth Observatory THE VIRTUOUS LINK BETWEEN PATIENTS, PHARMACIES AND PHARMACEUTICAL GROUPS.
Report for the Global South ehealth Observatory MCLINICA, THE VIRTUOUS LINK BETWEEN PATIENTS, PHARMACIES AND PHARMACEUTICAL GROUPS Arnaud Auger January 2016, Manila, Philippines Meeting with Farouk Meralli,
More informationExecutive Summary Industry s Responsibility in Promoting Responsible Development and Use:
Executive Summary Artificial Intelligence (AI) is a suite of technologies capable of learning, reasoning, adapting, and performing tasks in ways inspired by the human mind. With access to data and the
More informationNew Realities Facing the Mining and Metals Industry
New Realities Facing the Mining and Metals Industry The business of sustainability 2 ERM New Realities Facing the Mining and Metals Industry Working within the new realities in mining Changing global geo-political
More informationAt the forefront of Abu Dhabi s economic diversification. August 2008
At the forefront of Abu Dhabi s economic diversification August 2008 Mubadala was established by the Government transformation of Abu Dhabi. to help drive the situation analysis 4 HIGH 3 Financial Return
More informationREGISTER OF THE INTERESTS OF MEMBERS OF THE TRUST BOARD
REGISTER OF THE INTERESTS OF MEMBERS OF THE TRUST BOARD Board Member and Dominic Dodd, Chair 8/4/16 Non-executive s ships ship Director of UCLPartners 1 Member of I s Chairs Advisory Group. Unpaid. to
More informationCareer Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference
Career Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference November 13, 2007 Safe Harbor This presentation contains certain forward-looking statements, as defined in Section 21E of the
More informationKKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018
KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 ($ in trillions) KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR +21% CAGR Alternative AUM +12% CAGR $190 (1) ($ in billions)
More informationOffice of Inspector General Update
Office of Inspector General Update 15th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 3, 2014 Mary E. Riordan, Senior Counsel Office of Counsel to the Inspector
More informationADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020
ADVANCING KNOWLEDGE FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020 Social sciences and humanities research addresses critical
More informationGORDON J. CAMPBELL 3 Peter Cooper Road, #12 C New York, New York
GORDON J. CAMPBELL 3 Peter Cooper Road, #12 C New York, New York 10010 646.373.4524 EMPLOYMENT: 2012 Current Professor of Practice New York University Robert F. Wagner Graduate School of Public Service
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationHalliburton and Baker Hughes Creating the leading oilfield services company
Halliburton and Baker Hughes Creating the leading oilfield services company Halliburton Investor Relations Contacts: Kelly Youngblood, Vice President Scott Danby, Manager 281.871.2688 or investors@halliburton.com
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More informationThe Shape of Things to Come: Massachusetts June 18, 2010 Newton Marriott Hotel
The Shape of Things to Come: Massachusetts 2020 June 18, 2010 Newton Marriott Hotel Mark Nemec, Ph.D Managing Director, Technology Industry Client Group Forrester Research Some Thoughts on The Reset Economy
More informationSpeaking with One Voice Unifying Scripps Under a Master Brand Strategy
Forum for Healthcare Strategists Healthcare Marketing Summit April 30, 2014 Speaking with One Voice Unifying Scripps Under a Master Brand Strategy Lynne Field, Strategy Director, Monigle Associates, Inc.
More information4 November The Manager Company Announcements Australia Securities Exchange Limited Level 4, Bridge Street SYDNEY NSW 2000
nib holdings limited Head Office 22 Honeysuckle Drive Newcastle NSW 2300 abn 51 125 633 856 t 13 14 63 f 02 4925 1999 e nib@nib.com.au w nib.com.au 4 November 2015 The Manager Company Announcements Australia
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationDraft executive summaries to target groups on industrial energy efficiency and material substitution in carbonintensive
Technology Executive Committee 29 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Draft executive summaries to target groups on industrial energy efficiency and material substitution
More informationTHE SUSTAINABLE COLOURS OF BEAUTY CHARTER. values. and COMMITMENTS
THE SUSTAINABLE COLOURS OF BEAUTY CHARTER of values and COMMITMENTS We believe in people, in respect, in responsibility. We believe in the future. A STORY IN THE FUTURE 40.000 sq m PRODUCTION PLANT OF
More informationA digital health age how to take on the challenges of this advancing field
Page 1 of 7 Custom Search HOME NEWS OPINION TECHNOLOGY ANALYSIS LATEST ISSU 20 September 2017 11:39 A digital health age how to take on the challenges of this advancing field by Norbert Haberland RSS Print
More informationWhat We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012
What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report: The Case for Change 1 Report of What We Heard: The Case for Change Consultation
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationGlobal citizenship at HP. Corporate accountability and governance. Overarching message
Global citizenship at HP Overarching message With HP s global reach comes global responsibility. We take our role seriously by being an economic, intellectual and social asset to the communities in which
More informationMichael T. Gass Practice Group Leader
Michael T. Gass Practice Group Leader T +1 (617) 248-4750 mgass@choate.com Mike Gass chairs Choate s Securities Litigation & Corporate Governance Group. Over his 30 year career Mike has developed a remarkably
More informationNASDAQ: CASI Partnering Presentation
NASDAQ: CASI Partnering Presentation Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationGetting Management Buy-In
Getting Management Buy-In Soft Sell Tie compliance to Core Values Corporate Mantra Competitive differentiation: Sell relationship safety to employees and customers (e.g., insurance: the good hands people
More informationThe Art of the Public Member: Maximizing Your Consumer Member in Public Protection
This article is based on a presentation by Troy Costales, Public Member and James D. Heider, Executive Director, Oregon Physical Therapist Licensing Board; Whitney Lawrence, Public Member and Melinda Richardson,
More informationFRAMEWORK Advances in biomedical technology are
TECHNOLOGY FRAMEWORK Advances in biomedical technology are occurring so rapidly that healthcare professionals can barely keep abreast of the changes. And these advances have cost hospitals dearly. They
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationANALYSIS OF GREAT LEADERS : Group 6
ANALYSIS OF GREAT LEADERS : Group 6 WHAT IS THE LEADER S VISION STATEMENT? LEADER 1 Name : Xavier NIEL Company : ILIAD He wants to be every day more creative and to be seen as a major on the phone and
More informationBeleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities
Beleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities Toronto, ON September 6, 2018 Beleave Inc. (CSE: BE) (OTCQX: BLEVF)
More information